Free Trial

iRhythm Technologies (IRTC) Stock Forecast & Price Target

$99.51
+2.75 (+2.84%)
(As of 07/5/2024 ET)

iRhythm Technologies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$131.22
31.87% Upside
High Forecast$165.00
Average Forecast$131.22
Low Forecast$110.00
TypeCurrent Forecast
7/7/23 to 7/6/24
1 Month Ago
6/7/23 to 6/6/24
3 Months Ago
4/8/23 to 4/7/24
1 Year Ago
7/7/22 to 7/7/23
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$131.22$134.00$135.11$151.00
Forecasted Upside31.87% Upside31.53% Upside28.98% Upside25.05% Upside

IRTC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IRTC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

iRhythm Technologies Stock vs. The Competition

TypeiRhythm TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.71
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside31.87% Upside996.42% Upside12.25% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/20/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Polark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$115.00+17.16%
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$133.00 ➝ $122.00+18.82%
5/3/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$137.00 ➝ $138.00+24.46%
2/23/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$142.00 ➝ $133.00+23.30%
12/22/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$115.00 ➝ $133.00+23.91%
12/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$110.00+23.37%
Why Conservative Americans Are Turning to Gold in 2024 (Ad)

Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and global conflicts are escalating. Under Biden's disastrous policies, our savings are being devalued faster than ever. Protecting your wealth has never been more urgent. That's why we've created 3 Essential Guides to help you navigate these uncertain times and ensure your savings last as long as you do.

Claim Your Kit Now
10/11/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$149.00 ➝ $135.00+55.62%
8/4/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$125.00 ➝ $165.00+41.72%
7/18/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$130.00+28.55%
6/8/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$165.00 ➝ $140.00+37.34%
5/5/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
2/7/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$150.00+41.99%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:09 AM ET.

IRTC Forecast - Frequently Asked Questions

What is iRhythm Technologies' forecast for 2024?

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for iRhythm Technologies is $131.22, with a high forecast of $165.00 and a low forecast of $110.00.

Should I buy or sell iRhythm Technologies stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares.

Does iRhythm Technologies's stock price have much upside?

According to analysts, iRhythm Technologies's stock has a predicted upside of 29.37% based on their 12-month stock forecasts.

Has iRhythm Technologies been upgraded by Wall Street analysts recently?

Over the previous 90 days, iRhythm Technologies's stock had 1 upgrade by analysts.

What analysts cover iRhythm Technologies?

iRhythm Technologies has been rated by research analysts at Canaccord Genuity Group, Needham & Company LLC, and Wolfe Research in the past 90 days.

Do Wall Street analysts like iRhythm Technologies more than its competitors?

Analysts like iRhythm Technologies more than other "medical" companies. The consensus rating for iRhythm Technologies is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how IRTC compares to other companies.


This page (NASDAQ:IRTC) was last updated on 7/6/2024 by MarketBeat.com Staff

From Our Partners